ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

FDA Opens New Pathway, Pfizer’s $10B GLP-1 Win, and Biotech’s Return to Offense — This Week in Biotech #78

Biotech Blueprint

14/11/2025 7 min

Listen "FDA Opens New Pathway, Pfizer’s $10B GLP-1 Win, and Biotech’s Return to Offense — This Week in Biotech #78"

Descargar episodio Ver en sitio original

Episode Synopsis

Subscribe to Biotech Blueprint for free at biotechblueprint.com. A week of rare regulatory momentum, strategic M&A, and meaningful clinical wins.

More episodes of the podcast Biotech Blueprint

CDC’s Autism Reversal Shocks Experts, mRNA Flu Shot Advances, Big Oncology Wins - This Week in Biotech #79 24/11/2025

Inside Sensible Biotechnologies: Reinventing mRNA Manufacturing 13/11/2025

Trump Reshapes Obesity Drug Prices, Novo Tops Pfizer Again — This Week in Biotech #77 08/11/2025

Novo tops Pfizer’s obesity bid; FDA moves to speed biosimilar approvals; Moderna–Merck rumors build — This Week in Biotech #76 31/10/2025

Drug launch prices soar; mRNA shots linked to longer cancer survival — This Week in Biotech #75 26/10/2025

How mRNA Could Defeat Latent Viruses and Train Immunity Against Cancer 21/10/2025

Trump cuts IVF & Medicaid drug prices; Novo buys Omeros; Lilly's GLP-1 orforglipron shines — This Week in Biotech #74 19/10/2025

Pharma Tariffs on Ice, FDA Limits Filings, Amgen’s PCSK9 Win — This Week in Biotech #72 Pharma Tariffs on Ice, FDA Limits Filings, Amgen’s PCSK9 Win — This Week in Biotech #72 03/10/2025

ACIP votes, Roche-89bio deal, Regeneron’s FOP win — This Week in Biotech #70 19/09/2025

The mRNA Revolution: Beyond COVID to Cancer, Flu and Herpes Vaccines 18/09/2025

Ver todos los episodios